Sumitomo Mitsui Trust Group
OCDX

Sumitomo Mitsui Trust Group’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio OCDX Stock Details OCDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-64,848
Closed -$1.21M – 1280
2022
Q1 		$1.21M Buy
+64,848
New +$1.17M ﹤0.01% 1031

Other funds holding OCDX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sumitomo Mitsui Trust Group's OCDX Position: Q2 2022 in Review

Sumitomo Mitsui Trust Group sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 64,848 shares — an estimated $1.21M sold.

Sumitomo Mitsui Trust Group first reported a position in OCDX in Q1 2022 and held it in 1 quarter. The position peaked at $1.21M in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • Sumitomo Mitsui Trust Group reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • Sumitomo Mitsui Trust Group sold 64,848 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $1.21M.
  • Sumitomo Mitsui Trust Group first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2022 and held it in 1 quarter.
  • Sumitomo Mitsui Trust Group's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $1.21M in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q2 2022, filed 26 Jul 2022.